![David Holbrook](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Holbrook
Directeur/Membre du Conseil chez
FRONTIER IP GROUP PLC
Fortune : 13 283 $ au 30/06/2026
Profil
David Mark Anthony Holbrook currently works at Liver Group Charity, as Chairman from 2016, NK:IO Ltd., as Chairman, the University of Cambridge, as Director-Life Sciences, Frontier IP Group Plc, as Independent Director from 2023, Oxford BioDynamics Plc, as Independent Non-Executive Director from 2019, MTI Partners Ltd., as Venture Partner, Cambridge Enterprise Ltd., as Investment Manager (Life Sciences) from 2016, and Ryse Asset Management LLP, as Principal.
Dr. Holbrook also formerly worked at IP2IPO Innovations Ltd., as Chief Executive Officer, Myconostica Ltd., as Chairman in 2009, Finsbury Worldwide Pharmaceutical Trust Plc, as Non-Executive Director from 2009 to 2010, Hunter-Fleming Ltd., as Non-Executive Director, ApaTech Ltd., as Director, Onyvax Ltd., as Executive Director, Roche Holding (UK) Ltd., as Director-Business Development, Lein Applied Diagnostics Ltd., as Director from 2009 to 2016, Eykona Medical Ltd., as Non-Executive Director from 2010 to 2014, Worldwide Healthcare Trust Plc, as Senior Independent Non-Executive Director from 2016 to 2021, Glaxo Wellcome Plc, as Manager-Worldwide Business Development, GSK Plc, as Principal, Wellcome Plc, as Manager, Lifearc, as Head-Seed Funds from 2018 to 2021, and Ai2 Ltd., as Principal from 2003 to 2013.
Dr. Holbrook received his graduate degree from the University of Oxford and Masters Business Admin degree from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FRONTIER IP GROUP PLC 0,08 % | 17/06/2026 | 69 020 ( 0,08 % ) | 13 283 $ | 30/06/2026 |
Postes actifs de David Holbrook
| Sociétés | Poste | Début |
|---|---|---|
| OXFORD BIODYNAMICS PLC | Directeur/Membre du Conseil | 05/04/2019 |
| FRONTIER IP GROUP PLC | Directeur/Membre du Conseil | 15/03/2023 |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ryse Asset Management LLP
 Ryse Asset Management LLP Investment ManagersFinance RYSE Asset Management invests in companies located across the globe. The firm focuses on the healthtech. It participates in seed and early stage capital requirements. | Private Equity Investor | - |
Liver Group Charity
 Liver Group Charity Miscellaneous Commercial ServicesCommercial Services Operates charity | Président | 01/06/2016 |
Cambridge Enterprise Ltd.
 Cambridge Enterprise Ltd. Investment ManagersFinance CEL invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, electronics, software and engineering. It provide financing for early stage capital requirements. | Private Equity Investor | 01/09/2016 |
MTI Partners Ltd.
 MTI Partners Ltd. Investment ManagersFinance MTI Partners is an active manger which invests in companies located in Europe. The firm focuses on health technology, net zero, digital and 3rd economy sectors. It provides financing for growth stage capital transactions. | Private Equity Investor | 01/01/2003 |
NK:IO Ltd.
 NK:IO Ltd. BiotechnologyHealth Technology Develops novel approaches to natural killer cell-mediated immunotherapy | Président | - |
Anciens postes connus de David Holbrook
| Sociétés | Poste | Fin |
|---|---|---|
| WORLDWIDE HEALTHCARE TRUST PLC | Directeur/Membre du Conseil | 08/07/2021 |
| ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de David Holbrook
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
Glaxo Wellcome Plc
 Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Finsbury Worldwide Pharmaceutical Trust Plc
 Finsbury Worldwide Pharmaceutical Trust Plc Investment Trusts/Mutual FundsMiscellaneous Closed-End Investment Fund/Investment Trust | Miscellaneous |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MTI Partners Ltd.
MTI Partners Ltd. Investment ManagersFinance MTI Partners is an active manger which invests in companies located in Europe. The firm focuses on health technology, net zero, digital and 3rd economy sectors. It provides financing for growth stage capital transactions. | Finance |
Wellcome Plc
 Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Operates as a charitable foundation for healthcare | Commercial Services |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hunter-Fleming Ltd.
 Hunter-Fleming Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
ApaTech Ltd.
 ApaTech Ltd. Medical SpecialtiesHealth Technology Provides bone graft technologies | Health Technology |
Onyvax Ltd.
 Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Develops cancer remedy therapies | Commercial Services |
Roche Holding (UK) Ltd.
 Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs | Health Technology |
IP2IPO Innovations Ltd.
 IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business development and technology transfer services | Commercial Services |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Operates as a life science medical research charity company | Commercial Services |
Myconostica Ltd.
 Myconostica Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops molecular diagnostic fungal testing kits | Electronic Technology |
Cambridge Enterprise Ltd.
Cambridge Enterprise Ltd. Investment ManagersFinance CEL invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, electronics, software and engineering. It provide financing for early stage capital requirements. | Finance |
Lein Applied Diagnostics Ltd.
 Lein Applied Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops and provides optical measurement and non-invasive diagnostics products | Health Technology |
Eykona Medical Ltd.
 Eykona Medical Ltd. Medical DistributorsDistribution Services Develops 3D imaging products | Distribution Services |
Ai2 Ltd.
 Ai2 Ltd. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Frontier IP Group Plc
 Frontier IP Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the commercialization of intellectual property | Commercial Services |
Worldwide Healthcare Trust Plc
 Worldwide Healthcare Trust Plc Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Oxford BioDynamics Plc
 Oxford BioDynamics Plc BiotechnologyHealth Technology Discovers and develops novel biomarkers | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Liver Group Charity
Liver Group Charity Miscellaneous Commercial ServicesCommercial Services Operates charity | Commercial Services |
Ryse Asset Management LLP
Ryse Asset Management LLP Investment ManagersFinance RYSE Asset Management invests in companies located across the globe. The firm focuses on the healthtech. It participates in seed and early stage capital requirements. | Finance |
NK:IO Ltd.
NK:IO Ltd. BiotechnologyHealth Technology Develops novel approaches to natural killer cell-mediated immunotherapy | Health Technology |
